347
Views
13
CrossRef citations to date
0
Altmetric
Research Article

The frequency of clinical pregnancy and implantation rate after cultivation of embryos in a medium with granulocyte macrophage colony-stimulating factor (GM-CSF) in patients with preceding failed attempts of ART

, , &

References

  • Radzinsky VE, Dimitrov VI, Miskova M. EU non-developing pregnancy. GEOTAR-Media 2009:200
  • Sidelnikov VM, Sucyich GT. Miscarriage: a guide for practitioners. MIA 2010:536
  • Sudoma IA, Masliy JV. Algorithm of examination and treatment of patients with multiple unsuccessful art programmes. The materials of the XVII international conference “Reproductive technology today and tomorrow”; 2007; Kazan. pp. 20–21
  • Coulam CB, Acacio B. Does immunotherapy for treatment of reproductive failure enhance live births? Am J Reprod Immunol 2012;67:296–304
  • D'Hooghe TM, Denys B, Spiessens C, et al. Is the endometriosis recurrence rate increased after ovarian hyperstimulation? Fertil Steril 2006;86:283–90
  • Levi-Setti PE, Colombo GV, Savasi V. Implantation failure in assisted reproduction technology and a critical approach to treatment. Ann NY Acad Sci 2004;1034:184–99
  • Seidov LA, Yavoriv KA. Paracrine regulators implantation (literature review). Probl Reprod 2010;3:7–10
  • Donaghay M, Lessey BA. Uterine receptivity: alterations associated with benign gynecological disease. Semin Reprod Med 2007;25:461–75
  • Segerer S, Kämmerer U, Kapp M, et al. Upregulation of chemokine and cytokine production during pregnancy. Gynecol Obstetr Invest 2009;67:145–50
  • Laird SM, Tuckerman EM, Li TC. Cytokine expression in the endometrium of women with implantation failure and recurrent miscarriage. Reprod Biomed Online 2006;13:13–23
  • Robertson SA. GM-CSF regulation of embryo development and pregnancy. Cytokine Growth Factor Rev 2007;18:287–98
  • Scarpellini F, Sbracia M. Effectiveness of GM-CSF 1 in the treatment of habitual abortion in a controlled study. Fertil Steril 2003;80:288
  • Scarpellini F, Sbracia M. Use of granulocyte colony-stimulating factor for the treatment of unexplained recurrent miscarriage: a randomized controlled trial. Human Reprod 2009;24:2703–8
  • Roth I, Corry DB, Locksley RM, et al. Human placental cytotrophoblasts produce the immunosuppressive cytokine interleukin 10. J Exp Med 1996;184:539–48
  • Laird SM, Tuckerman EM, Cork BA, et al. A review of immune cells and molecules in women with recurrent miscarriage. Hum Reprod Update 2003;9:163–74
  • Makhseed M, Raghupathy R, Azizieh F, et al. Th1 and Th2 cytokine profiles in recurrent abortus with successful pregnancy and with subsequent abortions. Hum Reprod 2001;16:2219–26
  • Dumoulin JC, Land JA, Van Montfoort EC, et al. Effect of in vitro culture of human embryos on birth weight of newborns. Hum Reprod 2010;25:605–12
  • Hardy K, Handysid AH, Winston RML. The human blastocyst: cell number, death and allocation during late preimplantation development in vitro. Development 1989;107:597–604
  • Hansen M, Kurinczuk J, Bower C, et al. The risk of major birth defects after intracytoplasmic sperm injection and in vitro fertilization. N Engl J Med 2002;346:725–30
  • Maher RM, Brueton LA, Bowdin SC, et al. Epigenetic risks related to assisted reproductive technologies: еpigenetics, imprinting, ART and icebergs? Hum Reprod 2003;18:2508–11
  • Imakawa K, Carlson KD, McGuire WJ, et al. Enhancement of ovine trophoblast interferon by granulocyte macrophage-colony stimulating factor: possible involvement of protein kinase C. J Molec Endocrinol 1997;19:121–30
  • Robertson SA. GM-CSF regulation of embryo development and pregnancy. Cytokine Growth Factor Rev 2007;18:287–98
  • Sfontouris IA, Lainas GT, Anagnostara K, et al. Effect of granulocyte-macrophage colony-stimulating factor (GM-CSF) on pregnancy rates in patients with multiple unsuccessful IVF attempts. Hum Reprod 2013;28:62
  • Sjoblom C, Wikland M, Robertson SA. Granulocyte−macrophage colony-stimulating factor promotes human blastocyst development in vitro. Hum Reprod 1999;14:3069–76
  • Sjoblom C, Roberts CT, Wikland M, et al. Granulocyte-macrophage colony-stimulating factor alleviates adverse consequences of embryo culture on fetal growth trajectory and placental morphogenesis. Endocrinology 2005;146:2142–53
  • Kim D, Kim M, Kang H, et al. The supplementation of granulocyte-macrophage colony-stimulating factor (GM-CSF) in culture medium improves the pregnancy rate in human ART programs. Fertil Steril 2001;76:S6
  • Sharkey AM, Robertson SA. Sperm and seminal plasma differentially regulate cytockine and chemokine protein expression by human cervical epithelial cells. J Reprod Immunol 2010;86:68
  • Perricone R, De Carolis C, Giacomelli R, et al. GM-CSF and pregnancy: evidence of significantly reduced blood concentrations in unexplained recurrent abortion efficiently reverted by intravenous immunoglobulin treatment. Am J Reprod Immunol 2003;50:232–7
  • Renzini MM, Dal Canto M, Coticchio G, et al. Clinical efficiency and perinatal outcome of ART cycles following embryo culture in the presence of GM-CSF in patients with miscarriage or early pregnancy loss history. Hum Reprod 2013;28:142
  • Ziebe S, Loft A, Povlsen BB, et al. A randomized clinical trial to evaluate the effect of granulocyte-macrophage colony-stimulating factor (GM-CSF) in embryo culture medium for in vitro fertilization. Fertil Steril 2013;99:1600–9
  • Elaimi A, Harper JC. The use of time-lapse imaging and FISH to study the effect of GM-CSF on development and aneuploidy in murine blastocysts. Hum Reprod 2012;27:162–205
  • Plokhinsky NA. Biometrics. Novosibirsk: The Academy of Sciences of the USSR; 1961
  • Lim KJ, et al. The role of T-helper cytokines in human reproduction. Fertil Steril 2000;73:136–42
  • Kostromina NU, Gordeeva VL, Monakhov IV, Zdanovsky VM. Application environment EmbryoGen for cultivation of oocytes and embryos. Materials of the XXIII international conference “Reproductive technology today and tomorrow” 2013; Volgograd; pp. 53–4
  • Richter KS. The importance of growth factors for preimplantation embryo development and in-vitro culture. Curr Opin Obstetr Gynecol 2008;20:292–304

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.